Article
Clinical validation of AdvanSure GenoBlot assay as primary screening and test of cure for human papillomavirus infection.
Annals of laboratory medicine - 1 Mar 2014
Kahng Jimin, Oh Eun-Jee, Lee Hae Nam, Lee Dae Woo, Kim Yonggoo
Abstract excerpt
BACKGROUND: Clinical specificity and sensitivity are essential factors in the adoption of a human papillomavirus (HPV) test as a primary screening tool and test of cure after treatment of cervical cancer and precancerous lesions (High-Risk-Lesion). Using histologically-confirmed High-Risk-Lesion-patient specimens with postoperative follow-ups, we performed clinical validation of the AdvanSure GenoBlot Assay...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
